Home LiteratureArticle Details

PMID: 1856736 Published · ppublish English Letter Research Support, Non-U.S. Gov't

The effect of zidovudine on chronic myelopathy associated with HTLV-1.

Journal of neurology ·Vol. 238 ·No. 2 ·1991-04-00 ·Pages 108-9

Gout O, Gessain A, Iba-Zizen M, Kouzan S, Bolgert F, de Thé G, Lyon-Caen O

Abstract

暂无摘要

MeSH Terms

Humans Paraparesis, Tropical Spastic/diagnosis,drug therapy Prognosis Prospective Studies Zidovudine/therapeutic use

Chemicals

Zidovudine

Authors & Affiliations

7 authors, click to expand affiliations / ORCID

Gout O

Gessain A

Iba-Zizen M

Kouzan S

Bolgert F

de Thé G

Lyon-Caen O

References (4)

4 references, click to expand

High human T-cell lymphotropic virus type I proviral DNA load with polyclonal integration in peripheral blood mononuclear cells of French West Indian, Guianese, and African patients with tropical spastic paraparesis.
Blood. 1990 Jan 15;75(2):428-33 PMID: 1967218
Rapid development of myelopathy after HTLV-I infection acquired by transfusion during cardiac transplantation.
N Engl J Med. 1990 Feb 8;322(6):383-8 PMID: 2300089
Transactivation of interleukin 2 and its receptor induces immune activation in human T-cell lymphotropic virus type I-associated myelopathy: pathogenic implications and a rationale for immunotherapy.
Proc Natl Acad Sci U S A. 1990 Jul;87(13):5218-22 PMID: 2367534
Pharmacological inhibition of in vitro infectivity of human T lymphotropic virus type I.
J Clin Invest. 1987 Aug;80(2):394-400 PMID: 3038956

Article Info

Journal

Journal of neurology

Abbr.

J Neurol

ISSN

0340-5354

DOI

Published

1991-04-00

Pages

108-9

Language

English

Region

Germany

NLM ID

0423161

Subset

External Links

Analysis Services